<DOC>
	<DOC>NCT02873468</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of three doses of fluticasone propionate oral (viscous suspension) on changes of eosinophilic infiltration in esophageal biopsies.</brief_summary>
	<brief_title>Safety and Efficacy of Three Doses of Oral Fluticasone Propionate in Adults With Eosinophilic Esophagitis</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Signed Consent of the patient; Participants presenting eosinophilic esophagitis confirmed by endoscopy with 15 eosinophils/hpf and clinical symptoms; Patients with any clinically significant disease that in the investigator opinion they can´t participate in the study; Patients with any laboratory finding or image finding that in the investigator opinion they can´t participate in the clinical trial; Patients with history of hypersensitivity to any of the formula compounds; Participation in clinical trial in the year prior to this study; Pregnancy or risk of pregnancy and lactating patients; Patients with diseases of the esophagus / erosive esophagitis;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>